Survival Analysis of Combined Traditional Chinese and Western Medicine Therapy for Lung Cancer

碩士 === 國立中正大學 === 資訊工程研究所 === 106 === This thesis analyzes whether there is a significant difference in the survival time between lung cancer patients treated with combining traditional Chinese medicine (TCM) and western medicine and lung cancer patients treated with western medicine. The research...

Full description

Bibliographic Details
Main Authors: YEH,JING-WENG, 葉錦文
Other Authors: LIN,NAI-WEI
Format: Others
Language:zh-TW
Published: 2018
Online Access:http://ndltd.ncl.edu.tw/handle/35896b
Description
Summary:碩士 === 國立中正大學 === 資訊工程研究所 === 106 === This thesis analyzes whether there is a significant difference in the survival time between lung cancer patients treated with combining traditional Chinese medicine (TCM) and western medicine and lung cancer patients treated with western medicine. The research data is based on the cancer registration database and patient information of Dalin Tzu Chi and Taipei Tzu Chi Hospital. There are a total of 1871 lung cancer patients in the research data including 228 data using the treatment of combined TCM and western medicine and 1643 data using western medicine. The chi-square test shows that there are significant differences in the distribution of many research variables. Therefore, the Kaplan-Meier survival analysis cannot be directly applied. The Cox risk regression analysis is then applied by stratifying the research variables that do not pass the PH assumption and identifying the research variables with interactions. The results of the analysis show that the risk of using western medicine treatment is about 50% higher than that of using combining TCM and western medicine. The survival time of using western medicine treatment is significantly better than that of using western medicine as well. The results of the analysis also shows that there are 8 herbs, 7 bi-herb combinations, and 2 formulas that have the effects of reducing the risk of death by 80 ~ 90% in the treatment of lung cancer.